Literature DB >> 23516041

Mitochondrial disease in childhood: nuclear encoded.

Amy C Goldstein1, Poonam Bhatia, Jodie M Vento.   

Abstract

Primary mitochondrial disorders are clinically and genetically heterogeneous, caused by an alteration(s) in either mitochondrial DNA or nuclear DNA, and affect the respiratory chain's ability to undergo oxidative phosphorylation, leading to decreased production of adenosine triphosphophate and subsequent energy failure. These disorders may present at any age, but children tend to have an acute onset of disease compared with subacute or slowly progressive presentation in adults. Varying organ involvement also contributes to the phenotypic spectrum seen in these disorders. The childhood presentation of primary mitochondrial disease is mainly due to nuclear DNA mutations, with mitochondrial DNA mutations being less frequent in childhood and more prominent in adulthood disease. The clinician should be aware of the pediatric presentation of mitochondrial disease and have an understanding of the myriad of nuclear genes responsible for these disorders. The nuclear genes can be best understood by utilizing a classification system of location and function within the mitochondria.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23516041      PMCID: PMC3625393          DOI: 10.1007/s13311-013-0185-6

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  137 in total

1.  Deficiency in complex II of the respiratory chain, presenting as a leukodystrophy in two sisters with Leigh syndrome.

Authors:  M Burgeois; F Goutieres; D Chretien; P Rustin; A Munnich; J Aicardi
Journal:  Brain Dev       Date:  1992-11       Impact factor: 1.961

2.  The clinical and biochemical implications of pyruvate carboxylase deficiency.

Authors:  D C DeVivo; M W Haymond; M P Leckie; Y L Bussman; D B McDougal; A S Pagliara
Journal:  J Clin Endocrinol Metab       Date:  1977-12       Impact factor: 5.958

3.  Secondary inhibition of multiple NAD-requiring dehydrogenases in respiratory chain complex I deficiency: possible metabolic markers for the primary defect.

Authors:  M J Bennett; W G Sherwood; K M Gibson; A B Burlina
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

Review 4.  Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease.

Authors:  D R Johns
Journal:  N Engl J Med       Date:  1995-09-07       Impact factor: 91.245

5.  Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness.

Authors:  Saskia B Wortmann; Frédéric M Vaz; Thatjana Gardeitchik; Lisenka E L M Vissers; G Herma Renkema; Janneke H M Schuurs-Hoeijmakers; Wim Kulik; Martin Lammens; Christin Christin; Leo A J Kluijtmans; Richard J Rodenburg; Leo G J Nijtmans; Anne Grünewald; Christine Klein; Joachim M Gerhold; Tamas Kozicz; Peter M van Hasselt; Magdalena Harakalova; Wigard Kloosterman; Ivo Barić; Ewa Pronicka; Sema Kalkan Ucar; Karin Naess; Kapil K Singhal; Zita Krumina; Christian Gilissen; Hans van Bokhoven; Joris A Veltman; Jan A M Smeitink; Dirk J Lefeber; Johannes N Spelbrink; Ron A Wevers; Eva Morava; Arjan P M de Brouwer
Journal:  Nat Genet       Date:  2012-06-10       Impact factor: 38.330

6.  Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency.

Authors:  T Bourgeron; P Rustin; D Chretien; M Birch-Machin; M Bourgeois; E Viegas-Péquignot; A Munnich; A Rötig
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

7.  POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement.

Authors:  G Van Goethem; P Luoma; M Rantamäki; A Al Memar; S Kaakkola; P Hackman; R Krahe; A Löfgren; J J Martin; P De Jonghe; A Suomalainen; B Udd; C Van Broeckhoven
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

8.  Mitochondrial encephalomyopathy with decreased succinate-cytochrome c reductase activity.

Authors:  J E Riggs; S S Schochet; A V Fakadej; A Papadimitriou; S DiMauro; T W Crosby; L Gutmann; R T Moxley
Journal:  Neurology       Date:  1984-01       Impact factor: 9.910

9.  The retinal manifestations of mitochondrial myopathy. A study of 22 cases.

Authors:  M A Mullie; A E Harding; R K Petty; H Ikeda; J A Morgan-Hughes; M D Sanders
Journal:  Arch Ophthalmol       Date:  1985-12

10.  Single muscle fibre analyses in 2 brothers with succinate dehydrogenase deficiency.

Authors:  H Reichmann; C Angelini
Journal:  Eur Neurol       Date:  1994       Impact factor: 1.710

View more
  10 in total

1.  Leukoencephalopathy due to Complex II Deficiency and Bi-Allelic SDHB Mutations: Further Cases and Implications for Genetic Counselling.

Authors:  Sabine Grønborg; Niklas Darin; Maria J Miranda; Bodil Damgaard; Jorge Asin Cayuela; Anders Oldfors; Gittan Kollberg; Thomas V O Hansen; Kirstine Ravn; Flemming Wibrand; Elsebet Østergaard
Journal:  JIMD Rep       Date:  2016-09-08

2.  Points to consider in the clinical use of NGS panels for mitochondrial disease: an analysis of gene inclusion and consent forms.

Authors:  Julia Platt; Rachel Cox; Gregory M Enns
Journal:  J Genet Couns       Date:  2014-01-08       Impact factor: 2.537

3.  Mitochondrial dysfunction underlies cognitive defects as a result of neural stem cell depletion and impaired neurogenesis.

Authors:  Mireille Khacho; Alysen Clark; Devon S Svoboda; Jason G MacLaurin; Diane C Lagace; David S Park; Ruth S Slack
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

4.  Chronic Hypoxia Inhibits Respiratory Complex IV Activity and Disrupts Mitochondrial Dynamics in the Fetal Guinea Pig Forebrain.

Authors:  Tabitha M Quebedeaux; Hong Song; Jamiu Giwa-Otusajo; Loren P Thompson
Journal:  Reprod Sci       Date:  2021-11-08       Impact factor: 3.060

Review 5.  Nutritional interventions in primary mitochondrial disorders: Developing an evidence base.

Authors:  Kathryn M Camp; Danuta Krotoski; Melissa A Parisi; Katrina A Gwinn; Bruce H Cohen; Christine S Cox; Gregory M Enns; Marni J Falk; Amy C Goldstein; Rashmi Gopal-Srivastava; Gráinne S Gorman; Stephen P Hersh; Michio Hirano; Freddie Ann Hoffman; Amel Karaa; Erin L MacLeod; Robert McFarland; Charles Mohan; Andrew E Mulberg; Joanne C Odenkirchen; Sumit Parikh; Patricia J Rutherford; Shawne K Suggs-Anderson; W H Wilson Tang; Jerry Vockley; Lynne A Wolfe; Steven Yannicelli; Philip E Yeske; Paul M Coates
Journal:  Mol Genet Metab       Date:  2016-09-20       Impact factor: 4.797

6.  Rapid identification of a novel complex I MT-ND3 m.10134C>A mutation in a Leigh syndrome patient.

Authors:  David K Miller; Minal J Menezes; Cas Simons; Lisa G Riley; Sandra T Cooper; Sean M Grimmond; David R Thorburn; John Christodoulou; Ryan J Taft
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

7.  Machine learning classifier for identification of damaging missense mutations exclusive to human mitochondrial DNA-encoded polypeptides.

Authors:  Antonio Martín-Navarro; Andrés Gaudioso-Simón; Jorge Álvarez-Jarreta; Julio Montoya; Elvira Mayordomo; Eduardo Ruiz-Pesini
Journal:  BMC Bioinformatics       Date:  2017-03-07       Impact factor: 3.169

8.  Rapamycin enhances survival in a Drosophila model of mitochondrial disease.

Authors:  Adrienne Wang; Jacob Mouser; Jason Pitt; Daniel Promislow; Matt Kaeberlein
Journal:  Oncotarget       Date:  2016-12-06

Review 9.  Myopathology of Adult and Paediatric Mitochondrial Diseases.

Authors:  Rahul Phadke
Journal:  J Clin Med       Date:  2017-07-04       Impact factor: 4.241

10.  Epilepsia Partialis Continua a Clinical Feature of a Missense Variant in the ADCK3 Gene and Poor Response to Therapy.

Authors:  Mahmoud Reza Ashrafi; Roya Haghighi; Reza Shervin Badv; Homa Ghabeli; Ali Reza Tavasoli; Elham Pourbakhtyaran; Zahra Rezaei; Nejat Mahdieh; Pouria Mohammadi; Morteza Heidari
Journal:  J Mol Neurosci       Date:  2022-03-11       Impact factor: 2.866

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.